Evidence map›Paper›PMID 39303721›Full record

ArticleMolecular cell2024

Large-scale map of RNA-binding protein interactomes across the mRNA life cycle.

Lena A Street, Katherine L Rothamel, Kristopher W Brannan, Wenhao Jin, Benjamin J Bokor, Kevin Dong, Kevin Rhine, Assael Madrigal, Norah Al-Azzam, Jenny Kim Kim and 10 more

Abstract read
In one paragraph

Article in Molecular cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Lena A StreetDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Katherine L RothamelDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Center for RNA Technologies and Therapeutics, University of California, San Diego, La Jolla, CA, USA.
Kristopher W BrannanCenter for RNA Therapeutics, Houston Methodist Research Institute, Houston, TX, USA; Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston, TX, USA.
Wenhao JinDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Benjamin J BokorDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Kevin DongDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Kevin RhineDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Assael MadrigalDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Norah Al-AzzamDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Jenny Kim KimDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Yanzhe MaDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Darvesh GorheDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Ahmed AbdouDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Erica WolinDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Orel MizrahiDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.
Joshua AhdoutDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Mayuresh MujumdarDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Ella Doron-MandelDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Marko JovanovicDepartment of Biological Sciences, Columbia University, New York, NY, USA. Electronic address: mj2794@columbia.edu.
Gene W YeoDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Center for RNA Technologies and Therapeutics, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA; Sanford Laboratories for Innovative Medicines, San Diego, CA, USA; Sanford Stem Cell Institute, Innovation Center, San Diego, CA, USA. Electronic address: geneyeo@ucsd.edu.

Funding

Functional RNA elements in the human genomeR01HG004659 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin Daniel Corbett, Eugene Wei-Ming Yeo · 2008 to 2026
$12.4M
Predoctoral and Postdoctoral Training in Cancer Cell BiologyT32CA067754 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEAN Y.J. WANG · 1995 to 2026
$6.5M
A comprehensive binding and functional map of human RNA-binding proteinsU24HG009889 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GRAVELEY, BRENTON R., YEO, EUGENE WEI-MING · 2022 to 2025
$5.5M
STAMP technology to enable single-cell and isoform-sensitive detection of RBP sitesR01HG011864 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YEO, EUGENE WEI-MING · 2021 to 2024
$4.0M
Extensive multiplexing of protein nucleic-acid interactions to comprehensively study gene expression regulation from chromatin to mRNA degradationR01HG012216 · NHGRI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GUTTMAN, MITCHELL, JOVANOVIC, MARKO · 2022 to 2025
$3.1M
Defining the programmed proteome rejuvenation underlying gametogenesisR01AG071869 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRAR, GLORIA ANN, JOVANOVIC, MARKO · 2021 to 2025
$2.9M
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)R01CA284315 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI JENNY C-N CHANG · 2023 to 2026
$2.6M
Ribo-STAMPEDE: novel tools for molecular profiling of brain cell typesRF1MH126719 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI LIPPI, GIORDANO, YEO, EUGENE WEI-MING · 2022 to 2022
$2.3M
Regulation of Protein Production Dynamics:RNA Binding Proteins and the Ribosome CodeR35GM128802 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI JOVANOVIC, MARKO · 2018 to 2022
$2.3M
Exploring functional complexes and disease networks within human RNA-binding protein interactomesK22NS112678 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRANNAN, KRISTOPHER · 2019 to 2024
$998k
How dynamic interactions of RNA binding proteins control activity-dependent translation in neuronsK99NS135103 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DORON-MANDEL, ELLA · 2024 to 2025
$246k
NCI NIH HHS R01 CA284315NCI NIH HHS T32 CA067754NHGRI NIH HHS R01 HG004659NHGRI NIH HHS R01 HG011864NHGRI NIH HHS R01 HG012216NHGRI NIH HHS U24 HG009889NIA NIH HHS R01 AG071869NIGMS NIH HHS R35 GM128802NIMH NIH HHS RF1 MH126719NINDS NIH HHS K22 NS112678NINDS NIH HHS K99 NS135103
6 · The paper itself

Abstract

mRNAs interact with RNA-binding proteins (RBPs) throughout their processing and maturation. While efforts have assigned RBPs to RNA substrates, less exploration has leveraged protein-protein interactions (PPIs) to study proteins in mRNA life-cycle stages. We generated an RNA-aware, RBP-centric PPI map across the mRNA life cycle in human cells by immunopurification-mass spectrometry (IP-MS) of ∼100 endogenous RBPs with and without RNase, augmented by size exclusion chromatography-mass spectrometry (SEC-MS). We identify 8,742 known and 20,802 unreported interactions between 1,125 proteins and determine that 73% of the IP-MS-identified interactions are RNA regulated. Our interactome links many proteins, some with unknown functions, to specific mRNA life-cycle stages, with nearly half associated with multiple stages. We demonstrate the value of this resource by characterizing the splicing and export functions of enhancer of rudimentary homolog (ERH), and by showing that small nuclear ribonucleoprotein U5 subunit 200 (SNRNP200) interacts with stress granule proteins and binds cytoplasmic RNA differently during stress.

Indexed as

Protein Interaction MapsRNA-Binding ProteinsRNA, MessengerHEK293 CellsHeLa CellsHumansMass SpectrometryProtein BindingProtein Interaction MappingRibonucleoproteins, Small NuclearRNA SplicingRibonucleoproteins, Small NuclearRNA-Binding ProteinsRNA, MessengerERHinteractomeIP-MSmRNA life-cycleprotein-protein interactionsRBPRNA-binding proteinsRNA-dependent protein interactionsSEC-MSSNRNP200

Identifiers

PMID39303721
PMCPMC11530141

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.